| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 9896011
[patent_doc_number] => 20150051210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-19
[patent_title] => 'Tyrosine Kinase Inhibitor Combinations and their Use'
[patent_app_type] => utility
[patent_app_number] => 14/388251
[patent_app_country] => US
[patent_app_date] => 2013-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11631
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388251
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388251 | Tyrosine Kinase Inhibitor Combinations and their Use | Mar 31, 2013 | Abandoned |
Array
(
[id] => 9865433
[patent_doc_number] => 20150045452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE'
[patent_app_type] => utility
[patent_app_number] => 14/384358
[patent_app_country] => US
[patent_app_date] => 2013-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9771
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384358
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/384358 | METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE | Mar 26, 2013 | Abandoned |
Array
(
[id] => 9865433
[patent_doc_number] => 20150045452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-12
[patent_title] => 'METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE'
[patent_app_type] => utility
[patent_app_number] => 14/384358
[patent_app_country] => US
[patent_app_date] => 2013-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9771
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14384358
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/384358 | METHOD FOR PRODUCING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE, AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID-TYPE CARBOXYMETHYLCELLULOSE | Mar 26, 2013 | Abandoned |
Array
(
[id] => 9397078
[patent_doc_number] => 20140094484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'SUSTAINED DELIVERY FORMULATIONS OF RAPAMYCIN COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/633572
[patent_app_country] => US
[patent_app_date] => 2012-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 24332
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13633572
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/633572 | SUSTAINED DELIVERY FORMULATIONS OF RAPAMYCIN COMPOUNDS | Oct 1, 2012 | Abandoned |
Array
(
[id] => 7767101
[patent_doc_number] => 20120034682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'Process for Separating High Purity Germ and Bran from Corn'
[patent_app_type] => utility
[patent_app_number] => 13/273572
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4415
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034682.pdf
[firstpage_image] =>[orig_patent_app_number] => 13273572
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273572 | Process for Separating High Purity Germ and Bran from Corn | Oct 13, 2011 | Abandoned |
Array
(
[id] => 8990508
[patent_doc_number] => 20130217789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'BIODEGRADABLE LIQUOGEL AND PH SENSITIVE NANOCARRIERS'
[patent_app_type] => utility
[patent_app_number] => 13/818782
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 10958
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13818782
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/818782 | BIODEGRADABLE LIQUOGEL AND PH SENSITIVE NANOCARRIERS | Sep 1, 2011 | Abandoned |
Array
(
[id] => 7776545
[patent_doc_number] => 20120039991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'USE OF APOPTOSIS INHIBITING COMPOUNDS IN DEGENERATIVE NEUROLOGICAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/211832
[patent_app_country] => US
[patent_app_date] => 2011-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13921
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20120039991.pdf
[firstpage_image] =>[orig_patent_app_number] => 13211832
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/211832 | USE OF APOPTOSIS INHIBITING COMPOUNDS IN DEGENERATIVE NEUROLOGICAL DISORDERS | Aug 16, 2011 | Abandoned |
Array
(
[id] => 7657329
[patent_doc_number] => 20110306598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'Use of the association of a sinus node if current inhibitor and an angiotensin-converting enzyme inhibitor in the treatment of heart failure'
[patent_app_type] => utility
[patent_app_number] => 13/134667
[patent_app_country] => US
[patent_app_date] => 2011-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3061
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306598.pdf
[firstpage_image] =>[orig_patent_app_number] => 13134667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/134667 | Use of the association of a sinus node if current inhibitor and an angiotensin-converting enzyme inhibitor in the treatment of heart failure | Jun 13, 2011 | Abandoned |
Array
(
[id] => 7657273
[patent_doc_number] => 20110306542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'NOVEL GLP-1 RECEPTOR STABILIZERS AND MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/157264
[patent_app_country] => US
[patent_app_date] => 2011-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25715
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306542.pdf
[firstpage_image] =>[orig_patent_app_number] => 13157264
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/157264 | GLP-1 receptor stabilizers and modulators | Jun 8, 2011 | Issued |
Array
(
[id] => 6070694
[patent_doc_number] => 20110045544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Treatment of Cellulosic Material and Enzymes Useful Therein'
[patent_app_type] => utility
[patent_app_number] => 12/917603
[patent_app_country] => US
[patent_app_date] => 2010-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 31097
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20110045544.pdf
[firstpage_image] =>[orig_patent_app_number] => 12917603
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/917603 | Treatment of cellulosic material and enzymes useful therein | Nov 1, 2010 | Issued |
Array
(
[id] => 5997061
[patent_doc_number] => 20110016542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'CANINE GENOME EDITING WITH ZINC FINGER NUCLEASES'
[patent_app_type] => utility
[patent_app_number] => 12/842839
[patent_app_country] => US
[patent_app_date] => 2010-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12521
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20110016542.pdf
[firstpage_image] =>[orig_patent_app_number] => 12842839
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/842839 | CANINE GENOME EDITING WITH ZINC FINGER NUCLEASES | Jul 22, 2010 | Abandoned |
Array
(
[id] => 8146882
[patent_doc_number] => 08163892
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-24
[patent_title] => 'Oncolytic virus replicating selectively in tumor cells'
[patent_app_type] => utility
[patent_app_number] => 12/839264
[patent_app_country] => US
[patent_app_date] => 2010-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8571
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/163/08163892.pdf
[firstpage_image] =>[orig_patent_app_number] => 12839264
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/839264 | Oncolytic virus replicating selectively in tumor cells | Jul 18, 2010 | Issued |
Array
(
[id] => 6149306
[patent_doc_number] => 20110020901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/821686
[patent_app_country] => US
[patent_app_date] => 2010-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 26154
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020901.pdf
[firstpage_image] =>[orig_patent_app_number] => 12821686
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/821686 | Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof | Jun 22, 2010 | Abandoned |
Array
(
[id] => 6125724
[patent_doc_number] => 20110086105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'METHODS FOR IDENTIFYING NOVEL NUCLEIC ACID REGULATORY ELEMENTS AND COMPOUNDS THAT AFFECT THE REGULATION'
[patent_app_type] => utility
[patent_app_number] => 12/781308
[patent_app_country] => US
[patent_app_date] => 2010-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7541
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086105.pdf
[firstpage_image] =>[orig_patent_app_number] => 12781308
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/781308 | METHODS FOR IDENTIFYING NOVEL NUCLEIC ACID REGULATORY ELEMENTS AND COMPOUNDS THAT AFFECT THE REGULATION | May 16, 2010 | Abandoned |
Array
(
[id] => 6567283
[patent_doc_number] => 20100223683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Isolated Polynucleotide Sequence with IRES Activity'
[patent_app_type] => utility
[patent_app_number] => 12/778408
[patent_app_country] => US
[patent_app_date] => 2010-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8049
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20100223683.pdf
[firstpage_image] =>[orig_patent_app_number] => 12778408
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/778408 | Isolated Polynucleotide Sequence with IRES Activity | May 11, 2010 | Abandoned |
Array
(
[id] => 6007868
[patent_doc_number] => 20110059899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein'
[patent_app_type] => utility
[patent_app_number] => 12/769595
[patent_app_country] => US
[patent_app_date] => 2010-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 26428
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059899.pdf
[firstpage_image] =>[orig_patent_app_number] => 12769595
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/769595 | Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein | Apr 27, 2010 | Abandoned |
Array
(
[id] => 7711876
[patent_doc_number] => 20120004199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'SCAFFOLDS'
[patent_app_type] => utility
[patent_app_number] => 13/255688
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10073
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255688
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/255688 | SCAFFOLDS | Mar 9, 2010 | Abandoned |
Array
(
[id] => 8555410
[patent_doc_number] => 08329882
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-11
[patent_title] => 'Genetic control of mammalian cells with synthetic RNA regulatory systems'
[patent_app_type] => utility
[patent_app_number] => 12/708506
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17312
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708506
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/708506 | Genetic control of mammalian cells with synthetic RNA regulatory systems | Feb 17, 2010 | Issued |
Array
(
[id] => 5943518
[patent_doc_number] => 20110104138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES'
[patent_app_type] => utility
[patent_app_number] => 12/611746
[patent_app_country] => US
[patent_app_date] => 2009-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18679
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12611746
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/611746 | USE OF THE INNATE IMMUNITY GENE OASL FOR PREVENTING OR TREATING INFECTION WITH NEGATIVE STRAND RNA VIRUSES | Nov 2, 2009 | Abandoned |
Array
(
[id] => 6333976
[patent_doc_number] => 20100115641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'GFP-TRANSFECTED CLON PIG, GT KNOCK-OUT CLON PIG AND METHODS FOR PRODUCTIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/579032
[patent_app_country] => US
[patent_app_date] => 2009-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9113
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20100115641.pdf
[firstpage_image] =>[orig_patent_app_number] => 12579032
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/579032 | GFP-TRANSFECTED CLON PIG, GT KNOCK-OUT CLON PIG AND METHODS FOR PRODUCTIONS THEREOF | Oct 13, 2009 | Abandoned |